The primary goal of the Wisconsin Alzheimer's Disease Center (ADRC) Neuropathology and Biomarkers Core (Core D) is to facilitate the investigation of Alzheimer's disease (AD) and other dementias by University of Wisconsin (UW) investigators. The Core will accomplish this goal by providing complete and state-of-the- art characterization of disease pathogenesis and progression through biomarker, genetic and neuroimaging analysis, definitive neuropathologic diagnosis at autopsy and the preparation, banking and provision of frozen and fixed, non-demented control and AD brain tissues. In addition, the Core will enhance access to specialized proteomic and genomic technology to empower research progress. In particular, the Core will:
Specific Aim 1 : Perform rapid autopsies, obtain and archive representative frozen and fixed tissue blocks from multiple brain regions on deceased individuals who are enrolled in the Wisconsin ADRC as well as normal elderly controls, and generate NACC compatible diagnostic information.
Specific Aim 2 : Provide biomarker and genetic analyses in support of Wisconsin ADRC investigators and the procurement and management of tissues (blood, saliva, CSF).
Specific Aim 3 : Provide high quality, cost effective, cell and molecular neuroscience equipment, technology, assays, expertise, and training to Wisconsin ADRC investigators. This includes access to fluorescence and confocal microscopy, as well as specialized cell and molecular technology including Real Time PCR, DMA microarray analysis, 2-Dimensional gel electrophoresis, mass spectrometry, DMA and peptide synthesis and sequencing and metabolomics analysis.
Specific Aim 4 : Provide a service and infrastructure for AD-related brain imaging research. 4a) Advise investigators on protocols and analytic approaches;4b) Link the expertise of the vast brain imaging community at UW to the needs of Wisconsin ADRC investigators;4c) Collect a minimal standardized set of brain images on all ADRC participants at baseline;4d) Provide a location for investigators to store their images and analyze their data. In aggregate, these integrated services will greatly enhance basic and translational AD and dementia research on the UW-Madison campus.

Public Health Relevance

An integrated set of core neuropathology, biomarkers and imaging services in this core will greatly empower ADRC researchers to implement transdisciplinary translational studies of AD. The core is organized to meet the needs of the ADRC as a whole and is oriented toward early detection of AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG033514-02
Application #
8051845
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
2
Fiscal Year
2010
Total Cost
$200,824
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Holden, Timothy R; Keller, Sarah; Kim, Alice et al. (2018) Procedural Framework to Facilitate Hospital-Based Informed Consent for Dementia Research. J Am Geriatr Soc 66:2243-2248
Betthauser, Tobey J; Cody, Karly A; Zammit, Matthew D et al. (2018) In vivo characterization and quantification of neurofibrillary tau PET radioligand [18F]MK-6240 in humans from Alzheimer's disease dementia to young controls. J Nucl Med :
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Hao, Ling; Wang, Jingxin; Page, David et al. (2018) Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer's Disease. Sci Rep 8:9291
Bettcher, Brianne M; Johnson, Sterling C; Fitch, Ryan et al. (2018) Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage. J Alzheimers Dis 62:385-397
Mueller, Kimberly D; Koscik, Rebecca L; Clark, Lindsay R et al. (2018) The Latent Structure and Test-Retest Stability of Connected Language Measures in the Wisconsin Registry for Alzheimer's Prevention (WRAP). Arch Clin Neuropsychol 33:993-1005
Zhou, Hao Henry; Singh, Vikas; Johnson, Sterling C et al. (2018) Statistical tests and identifiability conditions for pooling and analyzing multisite datasets. Proc Natl Acad Sci U S A 115:1481-1486
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360

Showing the most recent 10 out of 374 publications